<DOC>
	<DOCNO>NCT02800746</DOCNO>
	<brief_summary>The objective present study determine impact preoperative IV-iron ( ferric carboxy maltose ) supplementation postoperative hematocrit value allogenic blood transfusion amount patient undergo elective prognathic surgery .</brief_summary>
	<brief_title>Intravenous Iron Iron Prognathic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Patients prognathism undergo elective prognathic surgery Patients provide write informed consent . Patients sferritin &lt; 300 mg/dl ( male ) 200 mg/dl ( female ) Patients preoperative Hematocrit &gt; 39 % ( male ) &gt; 36 % 9female ) serum hemoglobin &gt; 13 g/dL ( male ) &gt; 12 g/dL ( female ) Patients history anaphylaxis , iron overload , active infection . Patients endocrine disease Patients receive receive intraoperative preoperative blood salvage , allogenic blood transfusion , antifibrinolytic agent recombinant human erythropoietin , undergo acute normovolemic hemodilution .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Prognathic surgery</keyword>
</DOC>